Literature DB >> 7297598

Analysis of pupillary dilation produced by analogs of clonidine.

M C Koss.   

Abstract

Pupillary responses to intravenous administration of clonidine and five congeneric derivatives of clonidine were observed in anesthetized cats. All of the agents tested produced a dose-dependent mydriasis of long duration. The order of potency for these compounds was clonidine (St-155) greater than St.375 greater than St-606 greater than St-608 greater than St-91. Pretreatment with yohimbine hydrochloride (0.5 mg/kg i.v.) shifted the dose-response curve for all of the compounds tested to the right. A CNS inhibition of parasympathetic nerve activity was demonstrated for clonidine and St-375 by means of direct recordings from the postganglionic ciliary nerves. An effect of high doses of St-91 on nerve activity was also observed. These results suggest that all the analogs of clonidine tested (with the possible exception of St-91) act like clonidine to produce mydriasis by a central alpha-adrenergic inhibition of parasympathetic outflow to the eye.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297598     DOI: 10.1016/0014-2999(81)90049-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Studies on the mechanism of clonidine-induced mydriasis in the rat.

Authors:  J A Hey; T Gherezghiher; M C Koss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

2.  Mechanism of dexamphetamine-induced mydriasis in the anaesthetized rat.

Authors:  J A Hey; T Ito; M C Koss
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats.

Authors:  M P Parale; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Alpha-methyl-DOPA induced mydriasis in the cat. Relationship between pupillary response and the oculomotor perfusate concentration of methyldopa and its metabolites.

Authors:  T Gherezghiher; M C Koss; H D Christensen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.